SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

12 Aug 2025 Evaluate
The Sales for the quarter ended June 2025 of Rs. 25883.00 million declined by -37.78% from Rs. 41602.00 millions.Net Profit for the quarter ended June 2025 dipped to Rs. 3847.00  millions from Rs. 17008.00 millions  in the corresponding previous quarter.Operating Profit reported a sharp decline to 7425.00 millions from 24795.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 25883.00 41602.00 -37.78 25883.00 41602.00 -37.78 151163.00 108187.00 39.72
Other Income 1571.00 1066.00 47.37 1571.00 1066.00 47.37 9058.00 11595.00 -21.88
PBIDT 7425.00 24795.00 -70.05 7425.00 24795.00 -70.05 84325.00 51435.00 63.94
Interest 1376.00 1154.00 19.24 1376.00 1154.00 19.24 4639.00 3907.00 18.74
PBDT 6049.00 23641.00 -74.41 6049.00 23641.00 -74.41 79686.00 47442.00 67.97
Depreciation 1300.00 1306.00 -0.46 1300.00 1306.00 -0.46 5239.00 5044.00 3.87
PBT 4749.00 22335.00 -78.74 4749.00 22335.00 -78.74 74447.00 42398.00 75.59
TAX 902.00 5327.00 -83.07 902.00 5327.00 -83.07 16698.00 7983.00 109.17
Deferred Tax 6.00 11.00 -45.45 6.00 11.00 -45.45 873.00 -1360.00 -164.19
PAT 3847.00 17008.00 -77.38 3847.00 17008.00 -77.38 57749.00 34415.00 67.80
Equity 1006.00 1006.00 0.00 1006.00 1006.00 0.00 1006.00 1006.00 0.00
PBIDTM(%) 28.69 59.60 -51.87 28.69 59.60 -51.87 55.78 47.54 17.33

Zydus Lifesciences Share Price

923.10 7.65 (0.84%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×